The Optimizing Care Model

A novel community pharmacy approach to enhance patient care delivery by leveraging the technician workforce through technician product verification

Kenneth Hohmeier, Aaron Garst, Lucy Adkins, Xinhua Yu, Shane P. Desselle, Micah Cost

Research output: Contribution to journalArticle

Abstract

Objectives: To explore initial outcomes of the Optimizing Care Model's impact on patient care through technician product verification after the first 3 months of implementation, including the model's impact on pharmacist workday composition, rates of patient care services delivered, and rates of product selection errors not identified during final product verification. Setting: Fourteen chain and independent community pharmacies licensed and located in Tennessee. Innovation: The Optimizing Care Model is an innovative approach to community pharmacy practice aiming to foster a new patient-centered care delivery model that expands clinical service delivery through task delegation to pharmacist extenders. Evaluation: A quasiexperimental 1-group pretest–posttest design was used. Study sites self-reported data from 3 months before and 3 months after implementation of the intervention. Results: Overall pharmacist time spent delivering patient care services increased significantly on implementation of the Optimizing Care Model (25% vs. 43%; P < 0.001), and time spent performing dispensing-related activities decreased significantly (63% vs. 37%; P = 0.02). There was a total increase in quantity of clinical services delivered to patients from baseline, but data from initial study outcomes did not reach statistical significance. At least 1 new clinical service provided under a collaborative practice agreement had been implemented by all 14 sites (100%) as of Spring 2018. Total undetected error rates were significantly less in the Optimizing Care Model phase compared to the traditional model (0.063% vs. 0.085%; P < 0.001). Conclusion: Initial results of the Optimizing Care Model demonstrate improved patient care through increased clinical service delivery versus the traditional model. Undetected error detection rates were low in both models, but lower in the Optimizing Care Model. The Optimizing Care Model may represent a novel approach to improving care for patients while creating efficiencies through a staff delegation model, providing pharmacists the opportunity to further evolve their practice and advance clinical care for patients.

Original languageEnglish (US)
JournalJournal of the American Pharmacists Association
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Pharmacies
Patient Care
Pharmacists
Patient-Centered Care
Outcome Assessment (Health Care)
Error detection
Innovation

All Science Journal Classification (ASJC) codes

  • Pharmacology (nursing)
  • Pharmacy
  • Pharmacology

Cite this

@article{e902501251424f62926f71f72b217ef3,
title = "The Optimizing Care Model: A novel community pharmacy approach to enhance patient care delivery by leveraging the technician workforce through technician product verification",
abstract = "Objectives: To explore initial outcomes of the Optimizing Care Model's impact on patient care through technician product verification after the first 3 months of implementation, including the model's impact on pharmacist workday composition, rates of patient care services delivered, and rates of product selection errors not identified during final product verification. Setting: Fourteen chain and independent community pharmacies licensed and located in Tennessee. Innovation: The Optimizing Care Model is an innovative approach to community pharmacy practice aiming to foster a new patient-centered care delivery model that expands clinical service delivery through task delegation to pharmacist extenders. Evaluation: A quasiexperimental 1-group pretest–posttest design was used. Study sites self-reported data from 3 months before and 3 months after implementation of the intervention. Results: Overall pharmacist time spent delivering patient care services increased significantly on implementation of the Optimizing Care Model (25{\%} vs. 43{\%}; P < 0.001), and time spent performing dispensing-related activities decreased significantly (63{\%} vs. 37{\%}; P = 0.02). There was a total increase in quantity of clinical services delivered to patients from baseline, but data from initial study outcomes did not reach statistical significance. At least 1 new clinical service provided under a collaborative practice agreement had been implemented by all 14 sites (100{\%}) as of Spring 2018. Total undetected error rates were significantly less in the Optimizing Care Model phase compared to the traditional model (0.063{\%} vs. 0.085{\%}; P < 0.001). Conclusion: Initial results of the Optimizing Care Model demonstrate improved patient care through increased clinical service delivery versus the traditional model. Undetected error detection rates were low in both models, but lower in the Optimizing Care Model. The Optimizing Care Model may represent a novel approach to improving care for patients while creating efficiencies through a staff delegation model, providing pharmacists the opportunity to further evolve their practice and advance clinical care for patients.",
author = "Kenneth Hohmeier and Aaron Garst and Lucy Adkins and Xinhua Yu and Desselle, {Shane P.} and Micah Cost",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.japh.2019.07.009",
language = "English (US)",
journal = "Journal of the American Pharmacists Association : JAPhA",
issn = "1544-3191",
publisher = "American Pharmacists Association",

}

TY - JOUR

T1 - The Optimizing Care Model

T2 - A novel community pharmacy approach to enhance patient care delivery by leveraging the technician workforce through technician product verification

AU - Hohmeier, Kenneth

AU - Garst, Aaron

AU - Adkins, Lucy

AU - Yu, Xinhua

AU - Desselle, Shane P.

AU - Cost, Micah

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: To explore initial outcomes of the Optimizing Care Model's impact on patient care through technician product verification after the first 3 months of implementation, including the model's impact on pharmacist workday composition, rates of patient care services delivered, and rates of product selection errors not identified during final product verification. Setting: Fourteen chain and independent community pharmacies licensed and located in Tennessee. Innovation: The Optimizing Care Model is an innovative approach to community pharmacy practice aiming to foster a new patient-centered care delivery model that expands clinical service delivery through task delegation to pharmacist extenders. Evaluation: A quasiexperimental 1-group pretest–posttest design was used. Study sites self-reported data from 3 months before and 3 months after implementation of the intervention. Results: Overall pharmacist time spent delivering patient care services increased significantly on implementation of the Optimizing Care Model (25% vs. 43%; P < 0.001), and time spent performing dispensing-related activities decreased significantly (63% vs. 37%; P = 0.02). There was a total increase in quantity of clinical services delivered to patients from baseline, but data from initial study outcomes did not reach statistical significance. At least 1 new clinical service provided under a collaborative practice agreement had been implemented by all 14 sites (100%) as of Spring 2018. Total undetected error rates were significantly less in the Optimizing Care Model phase compared to the traditional model (0.063% vs. 0.085%; P < 0.001). Conclusion: Initial results of the Optimizing Care Model demonstrate improved patient care through increased clinical service delivery versus the traditional model. Undetected error detection rates were low in both models, but lower in the Optimizing Care Model. The Optimizing Care Model may represent a novel approach to improving care for patients while creating efficiencies through a staff delegation model, providing pharmacists the opportunity to further evolve their practice and advance clinical care for patients.

AB - Objectives: To explore initial outcomes of the Optimizing Care Model's impact on patient care through technician product verification after the first 3 months of implementation, including the model's impact on pharmacist workday composition, rates of patient care services delivered, and rates of product selection errors not identified during final product verification. Setting: Fourteen chain and independent community pharmacies licensed and located in Tennessee. Innovation: The Optimizing Care Model is an innovative approach to community pharmacy practice aiming to foster a new patient-centered care delivery model that expands clinical service delivery through task delegation to pharmacist extenders. Evaluation: A quasiexperimental 1-group pretest–posttest design was used. Study sites self-reported data from 3 months before and 3 months after implementation of the intervention. Results: Overall pharmacist time spent delivering patient care services increased significantly on implementation of the Optimizing Care Model (25% vs. 43%; P < 0.001), and time spent performing dispensing-related activities decreased significantly (63% vs. 37%; P = 0.02). There was a total increase in quantity of clinical services delivered to patients from baseline, but data from initial study outcomes did not reach statistical significance. At least 1 new clinical service provided under a collaborative practice agreement had been implemented by all 14 sites (100%) as of Spring 2018. Total undetected error rates were significantly less in the Optimizing Care Model phase compared to the traditional model (0.063% vs. 0.085%; P < 0.001). Conclusion: Initial results of the Optimizing Care Model demonstrate improved patient care through increased clinical service delivery versus the traditional model. Undetected error detection rates were low in both models, but lower in the Optimizing Care Model. The Optimizing Care Model may represent a novel approach to improving care for patients while creating efficiencies through a staff delegation model, providing pharmacists the opportunity to further evolve their practice and advance clinical care for patients.

UR - http://www.scopus.com/inward/record.url?scp=85071398984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071398984&partnerID=8YFLogxK

U2 - 10.1016/j.japh.2019.07.009

DO - 10.1016/j.japh.2019.07.009

M3 - Article

JO - Journal of the American Pharmacists Association : JAPhA

JF - Journal of the American Pharmacists Association : JAPhA

SN - 1544-3191

ER -